## NUE: Nucor Corporation - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_10 0.8% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($158.63)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 2, Bearish: 1)

**1. Nucor Corp. stock outperforms competitors on strong trading day**
- Source: MarketWatch | 20251224T165600 | Bullish | Relevance: 100%
- Shares of Nucor Corp. (NUE) rose 1.10% to $165.49 on Wednesday, outperforming the S&P 500 Index and the Dow Jones Industrial Average on a positive trading day. The stock closed 1.53% below its 52-week high of $168.07, achieved on December 11th.

**2. Is Nucor’s Trimmed Q4 Outlook and Leadership Shift Altering The Investment Case For Nucor (NUE)?**
- Source: Simply Wall Street | 20251224T023555 | Somewhat-Bearish | Relevance: 100%
- Nucor recently cut its Q4 2025 earnings guidance due to seasonal factors and fewer shipping days, coinciding with insider selling by executives. The company also announced Stephen D. Laxton will become President and COO as David A. Sumoski retires in June 2026. These developments, particularly the leadership transition amidst ongoing large capital projects, may influence investor sentiment and the long-term investment narrative for NUE.

**3. Nucor Corp Executives Engage in Stock Transactions**
- Source: TradingView — Track All Markets | 20251224T021003 | Somewhat-Bearish | Relevance: 100%
- Nucor Corp's Chair, President, and CEO, Leon J Topalian, sold 5,000 shares of common stock for $789,950 on December 19, 2025. Executive Vice President Allen C Behr also sold 5,950 shares for $939,445 on the same date. These transactions involved significant sales by top executives of the company.

**4. Jim Cramer on Nucor: “I Always Knew That Was a Good One”**
- Source: Insider Monkey | 20251228T111500 | Somewhat-Bullish | Relevance: 100%
- Jim Cramer expressed regret for not having "pushed hard" on Nucor Corporation (NYSE: NUE) stock, acknowledging its strong performance, up 40% for the year, in contrast to declines in other materials sectors like chemical companies. He noted Nucor's dependence on the Fed's interest rate decisions due to its steel business for data centers, making it sensitive to macroeconomic changes. Despite the stock's potential, Cramer suggested that some AI stocks might offer even higher returns in a shorter timeframe.

**5. Covea Finance Buys 40,500 Shares of Nucor Corporation $NUE**
- Source: MarketBeat | 20251226T100803 | Bullish | Relevance: 100%
- Covea Finance significantly increased its stake in Nucor Corporation, purchasing an additional 40,500 shares in Q3, bringing its total holdings to 94,200 shares valued at approximately $12.76 million. This move coincides with multiple brokerage firms raising their price targets for Nucor, resulting in a consensus "Moderate Buy" rating and a target price of $172.60. Nucor also reported strong quarterly earnings, beating analyst estimates with $2.63 EPS and $8.52 billion in revenue, and subsequently increased its quarterly dividend.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 3, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | Wells Fargo | $176 | $178 | -1% |
| 2025-12-15 | Wells Fargo | $178 | $167 | +7% |
| 2025-12-10 | Jefferies | $190 | $170 | +12% |
| 2025-12-05 | JP Morgan | $200 | $175 | +14% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | Wells Fargo | main | Overweight |
| 2025-12-15 | Wells Fargo | main | Overweight |
| 2025-12-10 | Jefferies | main | Buy |
| 2025-12-05 | JP Morgan | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 4 ($2.29M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 7 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (-3.1%)
- State Farm Mutual Au: 10.6% (-0.7%)
- Blackrock Inc.: 8.1% (-3.6%)
- State Street Corpora: 5.3% (-2.7%)
- Berkshire Hathaway, : 2.8% (-3.1%)

### Key Risks

1. High beta (1.86) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +11%) could attract flows.
- Momentum building: MRS_10 improving +2.4% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 0.75 indicates undervaluation relative to growth. Forward P/E 14.3x attractive for 47% earnings growth. Balance sheet: strong liquidity (2.8x). Analyst sentiment positive (3 raises, avg +11%). Insider selling cluster ($2.3M in 90 days), potential headwind. Institutional flow bullish (2 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $38.1B |
| Beta | 1.86 |
| 52W Range | $97.59 - $168.07 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.75 |
| Forward P/E | 14.3 |
| Current P/E | 21.0 |
| YoY Growth | 47.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -1.6% to 0.8% (+2.4% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.2pp (needs >3.0% for momentum thesis). MRS_5 at 1.2% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.79% (CS: 87) | Neutral |
| RSI_14 | 63.6 | Neutral |
| MACD Histogram | -0.20 | Bearish |
| vs SMA20 | 1.026x | Above |
| vs SMA50 | 1.092x | Above |
| vs SMA200 | 1.228x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $166.35
- **Stop Loss:** $158.63 (4.6% risk)
- **Target:** $174.07 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 170
- **Position Value:** $28,279.50
- **Portfolio %:** 28.28%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-01-26 (Est: $2.09)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.16 | $2.63 | +22.0% |
| 2025Q2 | $2.61 | $2.60 | -0.6% |
| 2025Q1 | $0.61 | $0.67 | +9.8% |
| 2024Q4 | $0.64 | $1.22 | +90.6% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*